Libo Pharma Corp. (TPEX:7888)
Taiwan · Delayed Price · Currency is TWD 40.00
+0.40 (1.01%)
At close: May 8, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 3.01 billion as of May 8, 2026.
Market Cap
3.01B
Enterprise Value
2.21B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
40.00
Market Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 3.01B, a decrease of -15.16%. That is a compound annual growth rate of -35.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.01B | -18.70% |
| Dec 31, 2025 | 3.70B | 4.35% |
| Dec 23, 2025 | 3.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 15.61B |
| TCM Biotech International | 9.21B |
| Taho Pharmaceuticals | 7.01B |
| Yoda Pharmaceuticals | 3.50B |
| TEH SENG Pharmaceutical Mfg. | 1.96B |
| Protect Animal Health | 1.95B |
| TSA International | 1.88B |
| Timing Pharmaceutial | 1.73B |